ConductScience.org, home

Paper42012273

Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration.

Shi J and 7 others. Invest Ophthalmol Vis Sci, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration. Papers, record 42012273. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42012273

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration.
PubMed
Journal
Invest Ophthalmol Vis Sci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shi JJiemei
2Xu HHuan
3Zhao HHongmei
4Zhao JJiajie
5Chen LLihui
6Xu PPing
7Jia DDan
8Jiang CChunhui

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Recombinant Fusion ProteinsMajor topic
Genetic TherapyMajor topic
Receptors, Vascular Endothelial Growth FactorMajor topic
DependovirusMajor topic
Choroidal NeovascularizationMajor topic
Macular DegenerationMajor topic
Wet Macular DegenerationMajor topic
Animals
Mice
Humans
Gene Therapy Agents
Disease Models, Animal
Vascular Endothelial Growth Factor A
Female
Genetic Vectors
Male
Treatment Outcome
Visual Acuity
Macaca fascicularis

Source PubMed

Download CSV of topics

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131146917Gene delivery to cone photoreceptors by subretinal injection of rAAV2/6 in the mouse retina.Biochem Biophys Res Commun2019https://conductscience.org/library/papers/31146917PubMed
230710128Adeno-associated virus vector as a platform for gene therapy delivery.Nat Rev Drug Discov2019https://conductscience.org/library/papers/30710128PubMed
321825187Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates.Arch Ophthalmol2011https://conductscience.org/library/papers/21825187PubMed
416644289Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection.Mol Ther2006https://conductscience.org/library/papers/16644289PubMed
522523653Anti-VEGF Treatment Strategies for Wet AMD.J Ophthalmol2012https://conductscience.org/library/papers/22523653PubMed
639908131Retinal and Choriocapillaris Thickness Changes in Spontaneously Diabetic Macaques.Invest Ophthalmol Vis Sci2025https://conductscience.org/library/papers/39908131PubMed
725360686Standardized full-field electroretinography in the Green Monkey (Chlorocebus sabaeus).PLoS One2014https://conductscience.org/library/papers/25360686PubMed
833767261High frequency SD-OCT follow-up leading to up to biweekly intravitreal ranibizumab treatment in neovascular age-related macular degeneration.Sci Rep2021https://conductscience.org/library/papers/33767261PubMed
929359172Nonclinical Safety Evaluation of scAAV8-RLBP1 for Treatment of RLBP1 Retinitis Pigmentosa.Mol Ther Methods Clin Dev2018https://conductscience.org/library/papers/29359172PubMed
1024144450Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.Ophthalmology2014https://conductscience.org/library/papers/24144450PubMed
1126603570Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal Diseases.Hum Gene Ther2016https://conductscience.org/library/papers/26603570PubMed
1224136346Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice.Nat Protoc2013https://conductscience.org/library/papers/24136346PubMed
132362376Aqueous protein concentration in rhegmatogenous retinal detachment.Jpn J Ophthalmol1990https://conductscience.org/library/papers/2362376PubMed
1435141350Delivery of nVEGFi using AAV8 for the treatment of neovascular age-related macular degeneration.Mol Ther Methods Clin Dev2022https://conductscience.org/library/papers/35141350PubMed
1538540673Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization.Biomolecules2024https://conductscience.org/library/papers/38540673PubMed
1632185075Silicone Oil Emulsification after Vitrectomy for Rhegmatogenous Retinal Detachment.J Ophthalmol2020https://conductscience.org/library/papers/32185075PubMed
1721119620Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration.Mol Ther2011https://conductscience.org/library/papers/21119620PubMed
1827111455
The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography.
Lasers Surg Med2016https://conductscience.org/library/papers/27111455PubMed
1930132368Dosage Thresholds and Influence of Transgene Cassette in Adeno-Associated Virus-Related Toxicity.Hum Gene Ther2018https://conductscience.org/library/papers/30132368PubMed
2038710714An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species.Nat Commun2024https://conductscience.org/library/papers/38710714PubMed

See all 51 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42012273

GET https://conductscience.org/api/papers/v1/42012273/references?page=2